×
Gou, Jiangtao

Sample size optimization and initial allocation of the significance levels in group sequential trials with multiple endpoints. (English) Zbl 1523.62122

Biom. J. 64, No. 2, 301-311 (2022).

Cited in 1 Document

MSC:

62P10 Applications of statistics to biology and medical sciences; meta analysis

Keywords:

multiple tests; multistage designs; power; sample size; trigger

Software:

multcomp
Cite Review PDF
Full Text: DOI

References:

[1] Bretz, F., Hothorn, T., & Westfall, P. (2010). Multiple comparisons using R. Chapman and Hall/CRC.
[2] Bretz, F., Maurer, W., Brannath, W., & Posch, M. (2009). A graphical approach to sequentially rejective multiple test procedures. Statistics in Medicine, 28, 586-604.
[3] Bretz, F., Posch, M., Glimm, E., Klinglmueller, F., Maurer, W., & Rohmeyer, K. (2011). Graphical approaches for multiple comparison procedures using weighted Bonferroni, Simes, or parametric tests. Biometrical Journal, 53, 894-913. · Zbl 1404.62118
[4] Broyden, C. G. (1965). A class of methods for solving nonlinear simultaneous equations. Mathematics of Computation, 19, 577-593. · Zbl 0131.13905
[5] Broyden, C. G. (1970). The convergence of a class of double‐rank minimization algorithms 1. General considerations. IMA Journal of Applied Mathematics, 6, 76-90. · Zbl 0223.65023
[6] Burman, C.‐F., Sonesson, C., & Guilbaud, O. (2009). A recycling framework for the construction of Bonferroni‐based multiple tests. Statistics in Medicine, 28, 739-761.
[7] Chow, S.‐C., & Chang, M. (2012). Adaptive design methods in clinical trials (2nd ed.). Chapman & Hall/CRC Biostatistics Series. CRC Press. · Zbl 1284.62027
[8] Coburger, S., & Wassmer, G. (2003). Sample size reassessment in adaptive clinical trials using a bias corrected estimate. Biometrical Journal, 45, 812-825. · Zbl 1441.62313
[9] Cui, L., Hung, H. M. J., & Wang, S.‐J. (1999). Modification of sample size in group sequential clinical trials. Biometrics, 55, 853-857. · Zbl 1059.62636
[10] Davidon, W. (1959). Variable metric method for minimization. Technical Report ANL‐5990, Argonne National Lab, Lemont, IL.
[11] Dmitrienko, A., Tamhane, A. C., & Bretz, F. (2009). Multiple testing problems in pharmaceutical statistics. Taylor & Francis.
[12] Fletcher, R. (1970). A new approach to variable metric algorithms. The Computer Journal, 13, 317-322. · Zbl 0207.17402
[13] Fletcher, R., & Powell, M. J. D. (1963). A rapidly convergent descent method for minimization. The Computer Journal, 6, 163-168. · Zbl 0132.11603
[14] Follmann, D. A., Proschan, M. A., & Geller, N. L. (1994). Monitoring pairwise comparisons in multi‐armed clinical trials. Biometrics, 50, 325-336. · Zbl 0822.62065
[15] Glimm, E., Maurer, W., & Bretz, F. (2010). Hierarchical testing of multiple endpoints in group‐sequential trials. Statistics in Medicine, 29, 219-228.
[16] Goldberg, D. (1989). Genetic algorithms in search, optimization and machine learning. Addison‐Wesley Professional. · Zbl 0721.68056
[17] Goldfarb, D. (1970). A family of variable‐metric methods derived by variational means. Mathematics of Computation, 24, 23-26. · Zbl 0196.18002
[18] Gou, J. (2020). Trigger strategy in repeated tests on multiple hypotheses. Submitted. The manuscript is available at https://raw.githubusercontent.com/jgvu/research/manuscripts/gsPhSplSz_v0s.pdf.
[19] Gou, J., & Chén, O. Y. (2019). Critical boundary refinement in a group sequential trial when the primary endpoint data accumulate faster than the secondary endpoint. In L.Zhang (ed.), D.‐G. D.Chen (ed.), H.Jiang (ed.), G.Li (ed.), & H.Quan (ed.) (Eds.), Contemporary biostatistics with biopharmaceutical applications (pp. 205-224). Springer International Publishing.
[20] Gou, J., & Tamhane, A. C. (2014). On generalized Simes critical constants. Biometrical Journal, 56, 1035-1054. · Zbl 1441.62356
[21] Gou, J., Tamhane, A. C., Xi, D., & Rom, D. (2014). A class of improved hybrid Hochberg‐Hommel type step‐up multiple test procedures. Biometrika, 101, 899-911. · Zbl 1306.62173
[22] Gou, J., & Xi, D. (2019). Hierarchical testing of a primary and a secondary endpoint in a group sequential design with different information times. Statistics in Biopharmaceutical Research, 11, 398-406.
[23] Graf, A. C., Bauer, P., Glimm, E., & Koenig, F. (2014). Maximum type 1 error rate inflation in multiarmed clinical trials with adaptive interim sample size modifications. Biometrical Journal, 56, 614-630. · Zbl 1441.62357
[24] Hochberg, Y., & Tamhane, A. C. (1987). Multiple comparison procedures. John Wiley and Sons. · Zbl 0731.62125
[25] Holland, J. H. (1975). Adaptation in natural and artificial systems: an introductory analysis with applications to biology, control, and artificial intelligence. University of Michigan Press. · Zbl 0317.68006
[26] Holm, S. (1979). A simple sequentially rejective multiple test procedure. Scandinavian Journal of Statistics, 6, 65-70. · Zbl 0402.62058
[27] Hommel, G. (2001). Adaptive modifications of hypotheses after an interim analysis. Biometrical Journal, 43, 581-589. · Zbl 1029.62083
[28] Hung, H. M. J., Wang, S.‐J., & O’Neill, R. (2007). Statistical considerations for testing multiple endpoints in group sequential or adaptive clinical trials. Journal of Biopharmaceutical Statistics, 17, 1201-1210.
[29] Hwang, I. K., Shih, W. J., & DeCani, J. S. (1990). Group sequential designs using a family of type I error probability spending functions. Statistics in Medicine, 9, 1439-1445.
[30] Jennison, C., & Turnbull, B. W. (2000). Group sequential methods with applications to clinical trials. Chapman and Hall/CRC. · Zbl 0934.62078
[31] Jennison, C., & Turnbull, B. W. (2003). Mid‐course sample size modification in clinical trials based on the observed treatment effect. Statistics in Medicine, 22, 971-993.
[32] Li, H., Wang, J., Luo, X., Grechko, J., & Jennison, C. (2018). Improved two‐stage group sequential procedures for testing a secondary endpoint after the primary endpoint achieves significance. Biometrical Journal, 60, 893-902. · Zbl 1405.62112
[33] Marcus, R., Peritz, E., & Gabriel, K. R. (1976). On closed testing procedures with special reference to ordered analysis of variance. Biometrika, 63, 655-660. · Zbl 0353.62037
[34] Maurer, W., & Bretz, F. (2013). Multiple testing in group sequential trials using graphical approaches. Statistics in Biopharmaceutical Research, 5, 311-320.
[35] O’Brien, P. C. (1984). Procedures for comparing samples with multiple endpoints. Biometrics, 40, 1079-1087.
[36] O’Brien, P. C., & Fleming, T. R. (1979). A multiple testing procedure for clinical trials. Biometrics, 35, 549-556.
[37] Pocock, S. J. (1977). Group sequential methods in the design and analysis of clinical trials. Biometrika, 64, 191-199.
[38] Proschan, M. A., Lan, K. K. G., & Wittes, J. T. (2006). Statistical monitoring of clinical trials: A unified approach. Springer. · Zbl 1121.62098
[39] Senn, S., & Bretz, F. (2007). Power and sample size when multiple endpoints are considered. Pharmaceutical Statistics, 6, 161-170.
[40] Shanno, D. F. (1970). Conditioning of quasi‐Newton methods for function minimization. Mathematics of Computation, 24, 647-656. · Zbl 0225.65073
[41] Tamhane, A. C., & Gou, J. (2018). Advances in p‐value based multiple test procedures. Journal of Biopharmaceutical Statistics, 28, 10-27.
[42] Tamhane, A. C., Gou, J., Jennison, C., Mehta, C. R., & Curto, T. (2018). A gatekeeping procedure to test a primary and a secondary endpoint in a group sequential design with multiple interim looks. Biometrics, 74, 40-48. · Zbl 1415.62138
[43] Tamhane, A. C., Mehta, C. R., & Liu, L. (2010). Testing a primary and a secondary endpoint in a group sequential design. Biometrics, 66, 1174-1184. · Zbl 1274.62881
[44] Tang, D.‐I., & Geller, N. L. (1999). Closed testing procedures for group sequential clinical trials with multiple endpoints. Biometrics, 55, 1188-1192. · Zbl 1059.62722
[45] Tang, D.‐I., Gnecco, C., & Geller, N. L. (1989). Design of group sequential clinical trials with multiple endpoints. Journal of the American Statistical Association, 84, 776-779.
[46] Vickerstaff, V., Omar, R. Z., & Ambler, G. (2019). Methods to adjust for multiple comparisons in the analysis and sample size calculation of randomised controlled trials with multiple primary outcomes. BMC Medical Research Methodology, 19, 129.
[47] Wassmer, G. (1999). Group sequential monitoring with arbitrary inspection times. Biometrical Journal, 41, 197-216. · Zbl 1053.62578
[48] Wassmer, G. (2006). Planning and analyzing adaptive group sequential survival trials. Biometrical Journal, 48, 714-729. · Zbl 1442.62684
[49] Xi, D., & Bretz, F. (2019). Symmetric graphs for equally weighted tests, with application to the Hochberg procedure. Statistics in Medicine, 38, 5268-5282.
[50] Xi, D., Glimm, E., Maurer, W., & Bretz, F. (2017). A unified framework for weighted parametric multiple test procedures. Biometrical Journal, 59, 918-931. · Zbl 1391.62260
[51] Xi, D., & Tamhane, A. C. (2015). Allocating recycled significance levels in group sequential procedures for multiple endpoints. Biometrical Journal, 57, 90-107. · Zbl 1309.62019
[52] Xu, T., Qin, Q., & Wang, X. (2018). Defining information fractions in group sequential clinical trials with multiple endpoints. Contemporary Clinical Trials Communications, 10, 77-79.
[53] Zhang, F., & Gou, J. (2016). A p‐value model for theoretical power analysis and its applications in multiple testing procedures. BMC Medical Research Methodology, 16, 135.
[54] Zhang, F., & Gou, J. (2020). Refined critical boundary with enhanced statistical power for non‐directional two‐sided tests in group sequential designs with multiple endpoints. Statistical Papers, in press. https://doi.org/10.1007/s00362‐019‐01134‐7. · Zbl 1477.62219 · doi:10.1007/s00362‐019‐01134‐7
This reference list is based on information provided by the publisher or from digital mathematics libraries. Its items are heuristically matched to zbMATH identifiers and may contain data conversion errors. In some cases that data have been complemented/enhanced by data from zbMATH Open. This attempts to reflect the references listed in the original paper as accurately as possible without claiming completeness or a perfect matching.